|
|
|
|
Next-Generation Sequencing Analysis of NS5A and NS5B Minor Resistance-Associated Variants in Patients with HCV Genotype 3 Infection who Failed Treatment with Daclatasvir Plus Sofosbuvir
|
|
|
Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
McPhee F, Hernandez D, Zhou N
Bristol-Myers Squibb Research and Development, Wallingford, CT, USA
|
|
|
|
|
|
|